The case for offering AHSCT as a first-line treatment for MS
Gavin Giovannoni
0:00 / 0:00
The case for offering AHSCT as a first-line treatment for MS
3 243 просмотра · 3 года назад
Gavin Giovannoni
1,92 тыс. подписчиков
3 243 просмотра · 3 года назад
A talk I gave at the 3rd International Symposium on Stem Cell Treatment in Multiple Sclerosis , Friday 20th January 2023, Sheffield.
